Cognition Therapeutics Stock Price History
| CGTX Stock | USD 0.32 0.01 3.03% |
If you're considering investing in Cognition Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cognition Therapeutics stands at 0.32, as last reported on the 16th of May 2025, with the highest price reaching 0.33 and the lowest price hitting 0.31 during the day. Cognition Therapeutics secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16 % return per unit of risk over the last 3 months. Cognition Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cognition Therapeutics' Standard Deviation of 5.56, mean deviation of 4.23, and Risk Adjusted Performance of (0.24) to double-check the risk estimate we provide.
Cognition Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cognition | Build AI portfolio with Cognition Stock |
Sharpe Ratio = -0.1579
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CGTX |
Estimated Market Risk
| 5.58 actual daily | 50 50% of assets are less volatile |
Expected Return
| -0.88 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cognition Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cognition Therapeutics by adding Cognition Therapeutics to a well-diversified portfolio.
Cognition Therapeutics Stock Price History Chart
There are several ways to analyze Cognition Stock price data. The simplest method is using a basic Cognition candlestick price chart, which shows Cognition Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 19, 2025 | 0.63 |
| Lowest Price | May 9, 2025 | 0.3 |
Cognition Therapeutics May 16, 2025 Stock Price Synopsis
Various analyses of Cognition Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cognition Stock. It can be used to describe the percentage change in the price of Cognition Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cognition Stock.| Cognition Therapeutics Accumulation Distribution | 37,031 | |
| Cognition Therapeutics Price Daily Balance Of Power | (0.50) | |
| Cognition Therapeutics Price Action Indicator | (0.01) | |
| Cognition Therapeutics Price Rate Of Daily Change | 0.97 |
Cognition Therapeutics May 16, 2025 Stock Price Analysis
Cognition Stock Price History Data
The price series of Cognition Therapeutics for the period between Sat, Feb 15, 2025 and Fri, May 16, 2025 has a statistical range of 0.33 with a coefficient of variation of 17.16. The prices are distributed with arithmetic mean of 0.42. The median price for the last 90 days is 0.42.| Open | High | Low | Close | Volume | ||
05/15/2025 | 0.33 | 0.33 | 0.31 | 0.32 | 611,005 | |
05/14/2025 | 0.31 | 0.33 | 0.31 | 0.33 | 812,989 | |
05/13/2025 | 0.33 | 0.33 | 0.30 | 0.32 | 637,797 | |
05/12/2025 | 0.32 | 0.34 | 0.31 | 0.33 | 2,499,208 | |
05/09/2025 | 0.32 | 0.32 | 0.28 | 0.30 | 2,528,880 | |
05/08/2025 | 0.35 | 0.36 | 0.32 | 0.33 | 6,295,328 | |
05/07/2025 | 0.39 | 0.40 | 0.35 | 0.35 | 906,226 | |
05/06/2025 | 0.44 | 0.44 | 0.41 | 0.42 | 198,556 | |
05/05/2025 | 0.47 | 0.47 | 0.42 | 0.43 | 484,200 | |
05/02/2025 | 0.45 | 0.47 | 0.43 | 0.45 | 315,864 | |
05/01/2025 | 0.42 | 0.45 | 0.41 | 0.45 | 344,522 | |
04/30/2025 | 0.42 | 0.43 | 0.40 | 0.43 | 240,231 | |
04/29/2025 | 0.42 | 0.42 | 0.41 | 0.42 | 182,454 | |
04/28/2025 | 0.44 | 0.44 | 0.40 | 0.42 | 447,013 | |
04/25/2025 | 0.43 | 0.44 | 0.42 | 0.44 | 427,111 | |
04/24/2025 | 0.39 | 0.45 | 0.39 | 0.44 | 1,353,428 | |
04/23/2025 | 0.38 | 0.39 | 0.37 | 0.38 | 193,447 | |
04/22/2025 | 0.37 | 0.38 | 0.36 | 0.38 | 106,117 | |
04/21/2025 | 0.38 | 0.38 | 0.35 | 0.36 | 257,007 | |
04/17/2025 | 0.40 | 0.40 | 0.36 | 0.37 | 276,816 | |
04/16/2025 | 0.40 | 0.40 | 0.36 | 0.37 | 280,115 | |
04/15/2025 | 0.40 | 0.41 | 0.38 | 0.38 | 211,296 | |
04/14/2025 | 0.37 | 0.40 | 0.36 | 0.39 | 695,497 | |
04/11/2025 | 0.32 | 0.36 | 0.32 | 0.35 | 321,116 | |
04/10/2025 | 0.33 | 0.34 | 0.31 | 0.32 | 360,684 | |
04/09/2025 | 0.32 | 0.35 | 0.31 | 0.33 | 1,199,923 | |
04/08/2025 | 0.36 | 0.36 | 0.32 | 0.32 | 400,330 | |
04/07/2025 | 0.33 | 0.36 | 0.31 | 0.35 | 739,854 | |
04/04/2025 | 0.39 | 0.39 | 0.34 | 0.35 | 983,156 | |
04/03/2025 | 0.39 | 0.40 | 0.38 | 0.39 | 465,531 | |
04/02/2025 | 0.38 | 0.42 | 0.38 | 0.41 | 346,384 | |
04/01/2025 | 0.42 | 0.44 | 0.39 | 0.39 | 1,808,582 | |
03/31/2025 | 0.42 | 0.43 | 0.39 | 0.42 | 454,235 | |
03/28/2025 | 0.45 | 0.45 | 0.41 | 0.42 | 431,747 | |
03/27/2025 | 0.44 | 0.45 | 0.43 | 0.45 | 250,368 | |
03/26/2025 | 0.47 | 0.49 | 0.43 | 0.44 | 530,102 | |
03/25/2025 | 0.50 | 0.50 | 0.45 | 0.46 | 676,239 | |
03/24/2025 | 0.45 | 0.49 | 0.45 | 0.49 | 921,759 | |
03/21/2025 | 0.42 | 0.47 | 0.42 | 0.45 | 561,708 | |
03/20/2025 | 0.47 | 0.47 | 0.41 | 0.43 | 796,262 | |
03/19/2025 | 0.44 | 0.46 | 0.43 | 0.45 | 444,000 | |
03/18/2025 | 0.45 | 0.47 | 0.44 | 0.44 | 306,968 | |
03/17/2025 | 0.46 | 0.47 | 0.44 | 0.45 | 474,221 | |
03/14/2025 | 0.43 | 0.45 | 0.42 | 0.45 | 363,390 | |
03/13/2025 | 0.44 | 0.46 | 0.41 | 0.42 | 947,080 | |
03/12/2025 | 0.42 | 0.44 | 0.41 | 0.42 | 1,714,958 | |
03/11/2025 | 0.41 | 0.42 | 0.39 | 0.41 | 645,990 | |
03/10/2025 | 0.44 | 0.44 | 0.40 | 0.41 | 668,855 | |
03/07/2025 | 0.43 | 0.44 | 0.42 | 0.43 | 256,129 | |
03/06/2025 | 0.45 | 0.45 | 0.41 | 0.43 | 438,760 | |
03/05/2025 | 0.41 | 0.45 | 0.38 | 0.43 | 404,900 | |
03/04/2025 | 0.43 | 0.44 | 0.36 | 0.42 | 1,485,044 | |
03/03/2025 | 0.45 | 0.47 | 0.43 | 0.43 | 796,178 | |
02/28/2025 | 0.46 | 0.47 | 0.44 | 0.45 | 795,933 | |
02/27/2025 | 0.48 | 0.50 | 0.45 | 0.46 | 2,560,512 | |
02/26/2025 | 0.50 | 0.62 | 0.47 | 0.50 | 41,605,620 | |
02/25/2025 | 0.56 | 0.58 | 0.50 | 0.52 | 773,338 | |
02/24/2025 | 0.59 | 0.59 | 0.55 | 0.56 | 352,309 | |
02/21/2025 | 0.61 | 0.62 | 0.58 | 0.58 | 515,835 | |
02/20/2025 | 0.65 | 0.65 | 0.59 | 0.61 | 1,318,091 | |
02/19/2025 | 0.63 | 0.65 | 0.61 | 0.63 | 518,083 |
About Cognition Therapeutics Stock history
Cognition Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cognition is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cognition Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cognition Therapeutics stock prices may prove useful in developing a viable investing in Cognition Therapeutics
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York. Cognition Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
Cognition Therapeutics Stock Technical Analysis
Cognition Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Cognition Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cognition Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cognition Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cognition to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.24) | |||
| Jensen Alpha | (0.71) | |||
| Total Risk Alpha | (0.58) | |||
| Treynor Ratio | (0.56) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cognition Stock Analysis
When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.